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Medical records of 140 patients, diagnosed with multigland primary, secondary or tertiary 
hyperparathyroidism were reviewed.  Of those, 56 patients had complete preoperative 
parathyroid scintigraphy with subsequent surgical resection of abnormal glands.  Parathyroid 
scintigraphy at our institution utilizes 99mTc sestamibi (MIBI) and 123I, and consists of early 
and delayed pinhole MIBI images of the neck, MIBI-123I subtraction imaging, and MIBI single 
photon computed tomography (SPECT).  Four experienced nuclear medicine physician, without 
knowledge of clinical or laboratory results or final diagnosis, reviewed seven different imaging 
variations in separate sessions.  The imaging variations were early MIBI only (EARLY), delayed 
MIBI only (DELAYED), comparison of early and delayed MIBI (E-D), subtraction (SUB), all 
planar (PLANAR), SPECT only (SPECT), and all images (ALL).  The location of the abnormal 
parathyroid glands was recorded and compared with the embryologic designation of the 
abnormal glands assigned at the time of surgery. 
Results:  A total of 159 parathyroid lesions were removed from the 56 patients.  The accuracy 
of ALL imaging for correct localization of the abnormal parathyroid gland was 86%, 76%, 
76%, and 76% for each reader.  For all four readers, the accuracy of Early, Delayed, E-D, SUB, 
SPECT and PLANAR imaging in diagnosing the correct location of the abnormal parathyroid 
was not statistically significant from ALL.  
Conclusion:  Reviewing pinhole Early, Delayed, E-D, SUB, SPECT and PLANAR images is as 
accurate as ALL images for localizing the offending glands in multi-gland disease.  
